Samsung Biologics, a biotechnology company based in South Korea, announced plans to open its first U.S. manufacturing ...

M arking a significant expansion of the company’s global footprint and long-term commitment to the U.S. market, Samsung Biologics America (SBA) has entered into an agreement with GSK to acquire 100% ...

Total of 945 integrated projects in 2025, including 74 Phase III clinical projects and 25 commercial manufacturing projects209 new integrated projects in 2025 set a new record, with approximately 50% ...

In light of the strong desire to shorten timelines and lower cost for biologics such as monoclonals specially biosimilars, and address surging demand for complex proteins such as bispecific antibodies ...

Opinions expressed by Digital Journal contributors are their own. Bringing a new biologic drug from concept to clinic is a complex journey fraught with technical and regulatory hurdles. For ...

SHANGHAI, Oct. 28, 2024 /PRNewswire/ -- Chime Biologics, a leading global CDMO that enables its partners' success in biologics, today announced a strategic collaboration with MedPacto, a South Korean ...

Pharmaceutical manufacturing steps are often isolated in space and time. The synthesis, isolation and purification of the drug substance (DS) and the formulation of the drug product (DP) may be ...

WuXi Biologics introduces industry-leading digital twin platform PatroLab designed to transform bioprocessing and manufacturing: Shanghai Wednesday, January 14, 2026, 10:00 Hrs [I ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

CHENGDU, China, June 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has kicked off ...

Goldman Sachs and Quadria Capital-backed Aragen Life Sciences is expanding India’s role in its global operations as demand ...